In the ovarian cancer domain, potential biomarkers included ZNF217,32 implicated in cancer cell proliferation, invasion, and metastasis, and RBM, an upregulated gene acting as a regulator of variable pre-mRNA splicing, thereby influencing apoptosis through the modulation of apoptotic factors. Here, ZNF217 is linked to ovarian carcinoma.